Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial

To evaluate the efficacy and safety of ursodeoxycholic acid (UDCA) with oral solubilized formula in amyotrophic lateral sclerosis (ALS) patients, patients with probable or definite ALS were randomized to receive oral solubilized UDCA (3.5 g/140 mL/day) or placebo for 3 months after a run-in period o...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Ju-Hong, Hong, Yoon-Ho, Sung, Jung-Joon, Kim, Sung-Min, Lee, Jung Bok, Lee, Kwang-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271295/
https://www.ncbi.nlm.nih.gov/pubmed/22323869
http://dx.doi.org/10.3346/jkms.2012.27.2.200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271295/
https://www.ncbi.nlm.nih.gov/pubmed/22323869
http://dx.doi.org/10.3346/jkms.2012.27.2.200

Ejemplares similares